Primary study · included by 1 review

Predictors of Overall and Disease-Free Survival in Metastatic Castration-Resistant Prostate Cancer Patients Receiving 225Ac-PSMA-617 Radioligand Therapy.

Sathekge 2020 · Sathekge Mike, Bruchertseifer Frank, Vorster Mariza, et al. · Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2020

Included by

Beyond [177Lu]Lu-PSMA: a meta-analysis of safety and efficacy of emerging PSMA radioligand therapy agents.

Non-Cochrane · intervention · 2026 · cited as Sathekge 2020 · Reference list refs 21-53; Table 2; Supplementary Table 5

The review does not say which of its outcomes this study informs.

1 including review in total.